Skip to main content
Elsevier

Models of Seizures and Epilepsy

  • 2nd Edition - June 14, 2017
  • Latest edition
  • Editors: Asla Pitkänen, Paul Buckmaster DVM PhD, Aristea S Galanopoulou, Solomon L. Moshé
  • Language: English

Models of Seizures and Epilepsy, Second Edition, is a valuable, practical reference for investigators who are searching for the most appropriate laboratory models to address k… Read more

Description

Models of Seizures and Epilepsy, Second Edition, is a valuable, practical reference for investigators who are searching for the most appropriate laboratory models to address key questions in the field. The book also provides an important background for physicians, fellows, and students, offering insight into the potential for advances in epilepsy research as well as R&D drug development. Contents include the current spectrum of models available to model different epilepsy syndromes, epilepsy in transgenic animals, comorbidities in models of epilepsy, and novel technologies to study seizures and epilepsies in animals.

Key features

  • Provides a comprehensive reference detailing animal models of epilepsy and seizure
  • Offers insights on the use of novel technologies that can be applied in experimental epilepsy research
  • Edited by leading experts in the field that provide not only technical reviews of these models but also conceptual critiques
  • Comments on the strengths and limitations of various models, including their relationship to clinical phenomenology and their value in developing better understanding and treatments

Readership

Advanced graduate students, basic scientists and clinicians interested in epileptology, neuroscience, animal models, and R&D drug development

Table of contents

Introduction

1. What can we model?

2. Comparative biology and species effects on expression of epilepsy

3. Strain effects on expression of seizures and epilepsy

4. Good welfare practice in modeling seizures and epilepsy

5. Ethics in the Use of Animal Models of Seizures and Epilepsy

6. Regulatory aspects of drug development

7. Use of animal models for epilepsy research and therapy development

Technical and methodological issues

8. Monitoring for Seizures in Rodents

9. Behavioral characterization and scoring of seizures in rodents

10. Seizure mimics

11. Characterization of pathology

12. Monitoring cardiorespiratory and other physiological parameters during seizures in small animals

13. Behavioral and cognitive testing procedures in animal models of epilepsy

14. In vivo Imaging in rodents

In vitro and in silico models

15. Hippocampal in silico models of seizures and epilepsy

16. Neocortical/thalamic in silico models of seizures and epilepsy

17. iPS cells, stem cells

18. Hippocampus in vitro

19. Thalamus and cortex in vitro

20. Brain slices from human resected tissues

21. Organotypic Hippocampal Slice cultures as a Model of Post-traumatic Epileptogenesis

22. The in vitro isolated guinea pig brain in the study of ictogenesis

Non-mammalian in vivo models

23. Nematode C. elegans: Genetic Dissection of Pathways Regulating Seizure and Epileptic-like Behaviors

24. Drosophila

25. Xenopus laevis

26. Zebrafish models of epilepsy and epileptic seizures

Naturally occurring seizures and epilepsies in animals

27. Veterinarian’s perspective

28. Naturally occurring epilepsy and status epilepticus in dogs

29. Naturally Occurring Temporal Lobe Epilepsy in Cats

30. Naturally occurring epilepsy and status epilepticus in Sea lions

31. Baboon Model of Genetic Generalized Epilepsy

32. Genetic Models of Reflex Epilepsy and SUDEP in Rats and Mice

33. Genetic models of absence epilepsy in rats and mice

In vivo mammalian models of induced seizures and status epilepticus

34. Electrical stimulation

35. Systemic Chemoconvulsants Producing Acute Seizures in Adult Rodents

36. Focally applied chemoconvulsants

37. Models of Chemically-Induced Acute seizures and Epilepsy: Toxic compounds and drugs of addiction

38. Pharmacologically induced animal models of absence seizures

39. Models of seizures and status epilepticus early in life

In vivo mammalian models of acquired epilepsies

40. Tetanus toxin

41. Post-SE models: Systemic kainic acid

42. Post-SE models: Focal kainic acid

43. The Pilocarpine Model of Acquired Epilepsy

44. Post-Status Epilepticus models: Electrical stimulation

45. Post-SE models: Hyperthermia

46. Epilepsy after TBI

47. Post-infectious epilepsy

48. Post-perinatal hypoxia

49. Perinatal Hypoxic-Ischemic Encephalopathy: A Model of Stroke-Induced Pediatric Epilepsy

50. Post-stroke epilepsy

51. Animal Models of Drug-Refractory Epilepsy

In vivo mammalian models of genetic epilepsies with identified gene

52. Spontaneous and Gene-Directed Epilepsy Mutations in the Mouse

53. Dravet and GEFS+ syndromes

54. Tuberous sclerosis and other toropathies

Modeling conditions that predispose to seizures or epilepsy

55. Kindling (including fast and slow kindlers)

56. Human mutations associated with brain malformations resulting in hyperexcitability in rodents

57. Dysplasias - Cortical freeze lesion

58. Dysplasia – MAM, model of developmental epilepsy

59. Dysplasias - In utero irradiation

60. Undercut cortex

61. Brain tumor–related epilepsy

62. Withdrawal seizures

63. Perimenstrual seizures and neurosteroid withdrawal

64. Metabolic disturbances: Hypo- and hyperglycemic seizures in vivo and in vitro

65. Stress

66. Blood Brain Barrier disruption

67. Experimental models of inflammation in epilepsy research

Other specific epilepsy-related syndromes

68. Infantile spasms

69. Models of epileptic encephalopathies

70. Sudep Animal Models

Animal models of other brain diseases with altered seizure susceptibility

71. Epilepsy in Models of Alzheimer’s disease

72. Animal Models of Acquired Epilepsy and Tauopathies

73. Epilepsy in other neurodegenerative disorders: Huntington’s and Parkinson’s diseases

74. Animal models of other brain diseases with altered seizure susceptibility: Autism and Fragile X Syndrome

75. Epilepsy in Models of Rett syndrome

76. Models of depression

Conclusions

77. What do models model? What needs to be modeled?

Product details

  • Edition: 2
  • Latest edition
  • Published: June 14, 2017
  • Language: English

About the editors

AP

Asla Pitkänen

Dr. Pitkänen is currently a Professor of Neurobiology at the University of Eastern Finland in Kuopio, Finland. She has over a 30 years’ experience in working and developing animal models of acquired epilepsy and phenotyping of epilepsy models, using histologic and molecular analysis, behavioral tests, long-term video-EEG and MRI imaging. She is a leader in epilepsy research and has participated in several NINDS on Epilepsy Models Workshops and worked in several ILAE Committees related to preclinical modelling and use of models to develop better therapies for epilepsy. She has an h-index of 52 and has over 279 publications.
Affiliations and expertise
A.I.Virtanen Institute, University of Kuopio, Kuopio, Finland

PB

Paul Buckmaster DVM PhD

Dr. Buckmaster is an Associate Professor of Comparative Medicine and Neurology at Stanford University School of Medicine in Stanford, California. His laboratory uses electrophysiological and anatomical techniques to evaluate neuronal circuitry of temporal lobe structures in normal and epileptic brains. He is a veterinarian with 25 years of experience investigating mechanisms of temporal lobe epilepsy using anatomical and electrophysiological techniques. He has worked with a variety of mammalian species, including primates, carnivores, and rodents. He has an h-index of 29 and has published over 74 articles.
Affiliations and expertise
Stanford University School of Medicine, Stanford, CA USA

AG

Aristea S Galanopoulou

Dr. Galanopoulou is an Attending Physician at the Clinical Neuroscience Center and EEG lab at Montefiore, a Professor of Neurology and Neuroscience at Albert Einstein College of Medicine in Bronx, New York. She is also the co-chair of the AES/ILAE Translational Research Task Force of the ILAE, which works towards the optimization of the use of animal models of seizures, epilepsies, and comorbidities in epilepsy research. She is a clinical epileptologist with 15 years’ experience with epilepsy basic research using a variety of animal models and particularly models of early life seizures and epilepsies. She has an h-index of 29 and has published over 84 articles.
Affiliations and expertise
Albert Einstein College of Medicine, Bronx, NY USA

SM

Solomon L. Moshé

Dr. Moshé is the is the Charles Frost Chair in Neurosurgery and Neurology and Professor of Neurology, Neuroscience, and Pediatrics at Albert Einstein College of Medicine. He is the Director of Child Neurology and Clinical Neurophysiology Dr. He has been President of the International League Against Epilepsy, American Epilepsy Society and American Clinical Neurophysiology Society (1996-1997). He is the recipient of several honors and awards, including Teacher-Investigator Development Award; Jacob Javits Neuroscience Investigator Award from NIH; Michael Prize for Achievement in Epilepsy Research; The American Epilepsy Society Research Award; Ambassador for Epilepsy Award from the International League Against Epilepsy; the Gloor Award from the American Clinical Neurophysiology Society; J.E. Purkyne Honorary Medal in Biomedical Research by the Czech Academy of Sciences; the 2008 Mentor of the Year Award from Albert Einstein College of Medicine; The 2010 Global and Awareness Award from Citizens United for Research in Epilepsy; the First Saul R. Korey Award in Translational Science and Medicine, Albert Einstein College of Medicine in 2012; elected Foreign Member of the Russian Academy of Sciences and Fellow of the American Epilepsy Society 2016. Since 1979, his research has focused on understanding the mechanisms underlying age-related differences in epilepsy in humans and in animal models.
Affiliations and expertise
Albert Einstein College of Medicine, Bronx, NY, USA

View book on ScienceDirect

Read Models of Seizures and Epilepsy on ScienceDirect